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KEYWORD
West Nile virus in Egypt
Summary We conducted a prospective cohort study to determine prevalence and
incidence of West Nile virus (WNV) in Egypt. Cohorts were established in Upper (UE),
Middle (ME), and Lower (LE) Egypt. Additionally, a cross-sectional serosurvey was
performed in the North (NS) and South (SS) Sinai. Cohorts were bled initially and 1
year later. Sera were tested for WNV-IgG by ELISA and positive sera were conﬁrmed
by plaque reduction neutralization test (PRNT). Sentinel chicken ﬂocks placed in
the above sites were bled monthly for virus isolation and serology. Mosquitoes were
collected monthly from the above sites and tested for WNV. Human seroprevalence
rates were 35%, 27%, 14%, 1% and 7% in UE, ME, LE, NS and SS, respectively. Sero-
conversion rates were 18%, 17% and 7% in UE, ME and LE, respectively; 49% of the
seroconverters reported undiagnosed febrile illness. Sentinel chickens showed sero-
conversion in all study sites. WNV was isolated from both sentinel chickens and
mosquitoes in cohort sites. This study demonstrates that WNV was actively circulat-
ing during the study period in different areas in Egypt and causing febrile illness in
a considerable proportion of individuals in the study sites.
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IntroductionOutbreaks of arthropod borne viruses (arboviruses)
in the United States, Africa, the Middle East and
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astern Europe stress the need to study and under-
tand the epidemiology in locations where the
iruses are endemic. Though the complete genome
equences and phylogenetic analysis of West Nile
irus (WNV) has demonstrated that the Egyptian
train is different from the New York strain [1],
he disease burden caused by the WNV in Egypt
as not been assessed for over 15 years. WNV was
rst recognized in Egypt in the 1950s where serosur-
g Saud Bin Abdulaziz University for Health Sciences. All rights reserved.
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eys showed that 22% of children and 61% of adults
ad antibodies to WNV [2]. A study conducted in
he Alexandria Fever Hospital in 1968, found that
NV infection was the etiology in 14.6% of the chil-
ren admitted to the hospital with a febrile illness
3]. Whereas, a seroprevalence study conducted in
989 in the Nile Delta showed only 3% prevalence
f WNV in school children aged 8—14 years [4]. Pre-
iminary serological studies in 1999 demonstrated
he WNV was widely distributed in Egypt (NAMRU-3,
npublished data). However, there is little current
nformation on circulation of West Nile Virus in the
ile Delta and Valley in Egypt. The objective of this
ork was to study WNV in different geographical
reas in humans in Egypt.
aterials and methods
tudy sites
ive study sites were established during the period
999—2002 to reﬂect different geographical set-
ings in Egypt (Fig. 1) as follows:
. Upper Egypt (UE) in Qena Governorate, Middle
Egypt (ME) in Fayoum Governorate and Lower
v
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igure 1 Study site locations in Egypt. LE: Lower Egypt; ME: M
inai.55
Egypt (LE) in Sharqiya Governorate, for the
cohort study.
. North Sinai (NS) in Al Arish and South Sinai in
Nuweiba, for the cross-sectional study.
uman subjects
wo hundred families (assuming an average of 5
embers per family) or a total of 1000 individ-
als were recruited from each study site for the
ohort study. Families were selected by using a
andom number table. All families in the study
rea were assigned a unique number. All fam-
ly members who were permanent residents of
he study community and who anticipated remain-
ng in the community for the duration of the
tudy were enrolled. Following signing the informed
onsent and completing the questionnaires, the
ohorts were bled at the beginning of the study
nd 1-year later for those who tested negative at
he beginning of the study to detect seroconver-
ion to WNV. Each family in UE, ME, and LE was
isited quarterly by NAMRU-3 investigator to iden-
ify any clinical illness and forms were completed
ccordingly. Acute and convalescent serum samples
ere obtained from any family members reported
ever of undetermined origin during the study
iddle Egypt; UE: Upper Egypt; NS: North Sinai; SS: South
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period to be tested for seroconversion to WNV at
NAMRU-3.
First cohort consisted of 326 randomly cho-
sen families (2203 individuals) in UE. The second
cohort consisted of 249 families (1593 individuals)
in ME. The third cohort consisted of 279 families
(1292 individuals) in LE (Fig. 1). In addition, cross-
sectional samples were collected from 54 randomly
chosen families (202 individuals) in NS and 200 ran-
domly chosen families (675 individuals) in SS. Sera
from this segment were tested to determine the
prevalence of WNV in the study sites. Serum sam-
ples were sent to NAMRU-3 for testing.
Sentinel chickens
Conﬁrmed WNV antibody negative chicken ﬂocks
(20 chickens per site) were placed at all ﬁve sites
in close proximity to human residences and bled
(through the wing vein) monthly for the duration of
the study. Chicken sera were processed for virus iso-
lation and serology. Seroconverted chickens were
kept to follow up on antibody levels.
Mosquito collection
Mosquitoes were collected from the ﬁve study
sites for three nights monthly throughout the dura-
tion of the study using CDC light traps baited
with dry ice. Traps were placed around human
dwellings and chicken cages and operated at late
afternoon and retrieved early morning the next
day. Six light traps were placed at ﬁxed places
each night to provide monthly measures of the
species and density of the vectors. Live-ﬁeld-
collected mosquitoes were sorted by species over
a Chilled table; pools of 25 mosquitoes each were
placed in liquid nitrogen to be processed for virus
isolation [5].
Laboratory procedures
Serum samples were tested by indirect ELISA [6]
for IgG antibodies titers against WNV (ATCC VR-
82—–cell-slurry antigen, produced at NAMRU-3).
All ELISA positive samples (deﬁned as positive at
dilution ≥1:400) were conﬁrmed by the plaque
reduction neutralization test (PRNT) using 80% pos-
itive criterion.
Chicken sera and mosquito pools were processed
for virus isolation using 3 different cell lines (Vero,
BHK 21 and C6/36). The virus was identiﬁed by
the indirect immunoﬂuorescent antibody test (IFA)
using speciﬁc anti-WNV antibodies. Identiﬁcation
was conﬁrmed by RT-PCR [7] using speciﬁc primers
s
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hat amplify 93 bp fragment from the WNV accord-
ng to the GenBank isolate, GI #1149619.
tatistical analysis
ata was analyzed by SPSS statistical package (SPSS
nc., Chicago, IL, USA) with 95% conﬁdence inter-
als and the level of signiﬁcance was set to be
< 0.05.
esults
total of 5965 persons were enrolled at the ﬁve
tudy sites in Egypt over a 2-year period of time. Of
hose 5965 persons, the overall initial seropreva-
ence of WNV-IgG antibodies was 24%. The highest
as in UE (35%) followed by ME (27%), while the low-
st was in NS (1%). UE prevalence was signiﬁcantly
igher than the rest of the study sites and sites in
he Nile Valley were signiﬁcantly higher than the
wo sites on the Sinai Peninsula (Table 1).
The overall IgG seroconversion rate as detected
y ELISA at the three sites along the Nile River
as 15%. The seroconversion rates in UE and ME
18%, 17%, respectively) were signiﬁcantly higher
p < 0.001) than LE (7%) (Table 1). These rates
ncreased signiﬁcantly with age overall at the three
ites in the Nile River valley, p < 0.001 (Fig. 2). No
linical cases of WNV or any medical visits or hospi-
alization for undifferentiated febrile disease were
eported during the quarterly visits during the study
eriod. However, 220 of 477 (49%) individuals who
eroconverted to WNV reported fever of undiffer-
ntiated etiology, while 523 of non-seroconverted
ndividuals (n = 2983, 18%) reported fever during the
tudy period (p < 0.001).
Culex spp. were the most abundant type of
osquitoes collected during the study period in
ll sites except in UE where Aedes spp. were pre-
ominant (Table 2). Cx. antennatus was the most
ommon mosquito species in LE and ME, Cx. Perex-
guus in SS, while Cx. Pipiens was the most common
osquito species in UE and NS. Fifteen WNV isolates
11—73% of them from ME) identiﬁed by IFA and
onﬁrmed by RT-PCR were obtained from different
pecies.
Sentinel chickens showed seroconversion
etected by ELISA to WNV in all study sites,
ear-round, with titers up to 1:12,800. The highest
eroconversion rate was recorded in ME (47%),
ollowed by 17%, 9%, 5% and 4% in NS, UE, SS and
E, respectively. WNV was isolated from sera of 4
hickens (2 each from LE and UE) between May and
ctober 2001.
Studies on West Nile virus infection in Egypt 57
Table 1 Human seroprevalence and seroconversion to WNV in the 5 study sites.
Location Initial bleed One-year follow-up bleed
No. tested No. positive (%)a No. tested (% follow-upb) No. Positive (%)a
UE 2203 771 (35) 1281 (89) 231(18)
ME 1593 435 (27) 1057 (91) 174 (17)
LE 1292 178 (14) 984 (88) 72 (7)
NS 202 2 (1) — —
SS 675 45 (7) — —
Total 5965 1431 (24) 3322 (90) 477 (15)
* Statistically signiﬁcant difference between UE/ME and LE and between combined UE/ME/LE and combined NS/SS (p < 0.0001). #
Statistically signiﬁcant difference between UE/ME and LE (p < 0.000
a IgG positive at ≥1:400 dilution.
b % follow-up of individuals who were seronegative at the initial
Figure 2 Seroconversion1 rates (1negative ﬁrst bleed
and tested WNV-IgG seropositive at second bleed 1 year
later) to WNV by Age Groups in 3 regions of the Nile River.
UE: Upper Egypt Nile River Valley; ME: Middle Egypt Nile
River Valley; LE: Lower Egypt Nile River Valley.
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Table 2 Summarized results of the tested mosquitoes and
Location No. of mosquitoes and
sand ﬂies collected
Predominant
type (%)
NS 880 Culex (81)
SS 9398 Culex (99)
UE 40,937 Aedes (56)
Culex (37)
ME 34,770 Culex (97)
LE 26,170 Culex (99)
Total 112,1551).
bleed.
iscussion
verall initial point prevalence rate of WNV-IgG
ntibodies in Egypt from the ﬁve study sites was
4% (1431/5965). A similar prevalence rate (27%)
mong the general human population was reported
uring a WNV outbreak in Israel in 1999 [8], indi-
ates the endemicity of the virus in this region
f the Middle East. The high seroconversion rate
15%) detected in this study indicates that active
ransmission of the virus is occurring in the Nile
iver area, particularly in ME and UE regions of
gypt. Our results showed that adults had higher
eroconversion rates than children; a ﬁnding that
uggests adults had more frequent exposure to WNV
ompared to children, and that is supported by
he ﬁndings of previous studies on WNV endemicity
n Egypt [2,4]. Using active surveillance meth-
ds there were no hospitalized clinical cases of
N fever reported during the study period. This
ould be because the disease is self-limited for
eople living in this region or because of natu-
al immunity of the population (herd immunity).
sand ﬂies for WNV.
No. pools No. positive
WNV pools (%)
WNV PCR
positive species
216 0
484 0
1686 3 (0.18) C. pepiens
C. perexiguus
C. perexiguus
1897 11 (0.58) C. perexiguus
C. antennatus
C. poicilipes
An. pharoensis
Sand ﬂies
731 1 (0.14) C. antennatus
5014 15 (0.29)
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Another possibility is the circulation of less virulent
WNV strains; however, a recent preliminary study
(NAMRU-3 unpublished data) reported no difference
in virulence and pathogenicity between WNV iso-
lated from Egypt and New York when inoculated into
Egyptian crows. Interestingly, fever was reported
in 49% of the seroconverted individuals while only
18% (p < 0.001) reported fever in the none serocon-
verted group; this may indicate that reported fever
was due to exposure to WNV.
Mosquito distribution shows that the prevalent
species in the Sinai is Cx. pipiens while the preva-
lent species in the ME and LE regions is Cx.
antennatus. In UE the prevalent species was Aedes
caspius. These ﬁndings agree with the previously
reported mosquito distribution in Egypt [9]. The
most prevalent mosquito species overall was Culex
(mainly, Cx. pipiens, Cx. antennatus and Cx. perex-
iguus) which has been proven to be the primary
vector of WNV [10]. Moreover, most of the isolated
WNV in this study were from Culex species. It was
stated before (2) that even in areas where WNV is
circulating, very few mosquitoes are infected. Dur-
ing an intensive study in Egypt in 1951—1954, WNV
was only isolated in 1.7% of the pools tested. Iso-
lation rates from mosquitoes in the United States
have been similarly low even from gravid Culex
mosquitoes [11]. The overall isolation rate of WNV
from mosquito pools in our study was consider-
ably lower (0.29%) which indicates a low rate of
viral activity in mosquito’s communities in the study
sites.
Chickens have provided a more sensitive and
cost-effective means to early detection of arbovirus
activity in comparison to mosquito and wild bird-
based surveillance systems [12]. Seroconversion
and/or WNV isolated from sentinel chickens in
all study sites and the isolation of WNV from
mosquitoes again indicates active circulation of
the WNV in the study sites. The study sites in ME
were in the vicinity of Fayoum Oasis, which is a
major stop of migratory birds in transient to Sub
Saharan Africa. High seroconversion rates detected
among humans and sentinel chickens (17% and 47%,
respectively) and the highest isolation rate from
mosquitoes in ME could be a result of this large num-
ber of migratory birds which are known to have a
signiﬁcant role in WNV transmission [13]. In con-
clusion, WNV appears to be circulating in humans
in Egypt, much less in the Sinai compared to Nile
Delta and Nile Valley regions. The isolation of WNV
from mosquitoes and the seroconversion of sentinel
chickens indicate active circulation of the virus
in nature in Egypt. More reported febrile disease
among the seroconverted toWNV suggests thatWNV
is a common cause of undifferentiated fever. A lackA. Soliman et al.
f reported morbidity and hospitalization however,
ndicates that WNV in Egypt is a relatively mild dis-
ase.
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